Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.

Monami, Matteo; Nreu, Besmir; Scatena, Alessia; Cresci, Barbara; Andreozzi, Francesco; Sesti, Giorgio; Mannucci, Edoardo

Monami, Matteo; Nreu, Besmir; Scatena, Alessia; Cresci, Barbara; Andreozzi, Francesco; Sesti, Giorgio; Mannucci, Edoardo.

Affiliation

Monami M; Department of Diabetology, Azienda Ospedaliero Universitaria Careggi and University of Florence, Florence, Italy.
Nreu B; Department of Diabetology, Azienda Ospedaliero Universitaria Careggi and University of Florence, Florence, Italy.
Scatena A; Diabetology Unit, Osperdale San Donato Arezzo, Arezzo, Italy.
Cresci B; Department of Diabetology, Azienda Ospedaliero Universitaria Careggi and University of Florence, Florence, Italy.
Andreozzi F; Diabetology Unit, Osperdale San Donato Arezzo, Arezzo, Italy.
Sesti G; Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Mannucci E; Diabetology Unit, Osperdale San Donato Arezzo, Arezzo, Italy.

Diabetes Obes Metab ; 19(9): 1233-1241, 2017 09.

Article de En | MEDLINE | ID: mdl-28244632

Sujet(s)
Mots clés

GLP-1 analogue; meta-analysis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pancréas / Voies biliaires / Lithiase biliaire / Médecine factuelle / Diabète de type 2 / Récepteur du peptide-1 similaire au glucagon / Hypoglycémiants Type d'étude: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Diabetes Obes Metab Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2017 Type de document: Article Pays d'affiliation: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google